Monitoring multiple sclerosis by multimodal evoked potentials: Numerically versus ordinally scaled scoring systems

Clin Neurophysiol. 2016 Mar;127(3):1864-71. doi: 10.1016/j.clinph.2015.11.041. Epub 2015 Dec 10.

Abstract

Objective: To compare the ability of different evoked potential scores (EPS) to monitor and predict the disease course in multiple sclerosis (MS).

Methods: Seventy-two patients with MS or clinically isolated syndrome were investigated by visual, motor, and somatosensory EP and expanded disability status scale (EDSS) at baseline (T0) and months 6, 12, 24, 36 (T4). EP results were rated according to ordinal (o), semi-quantitative (sq), and quantitative (q) EPS. Spearman rank correlation and multivariable linear regression were used to investigate the associations between EPS and clinical disability.

Results: All EPS correlated with EDSS cross-sectionally (0.72⩽rho⩽0.87, all p<0.001) and longitudinally (0.39⩽rho⩽0.47, all p⩽0.004). EPS(T0) and EDSS(T0) together explained 85-86% of EDSS(T4) variance. A posteriori power calculation showed that the sample sizes needed to detect significant changes over 6 months in q-EPS, sq-EPS and o-EPS with 90% certainty would be 50, 129 and 222, respectively. q-EPS change(T1-T0) correlated with EDSS change(T4-T0) (rho=0.56, p<0.001), while sq-EPS and o-EPS changes(T1-T0) did not.

Conclusion: All three EPS allow disease course monitoring in MS. However, the quantitative EPS detects clinically relevant short-term changes with a smaller sample size than semi-quantitative or ordinal EPS.

Significance: These results underscore the potential of EPS to characterize MS disease evolution.

Keywords: Evoked potentials; Monitoring; Multiple sclerosis; Prognosis.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Cohort Studies
  • Cross-Sectional Studies
  • Disease Progression
  • Evoked Potentials, Motor / physiology*
  • Evoked Potentials, Somatosensory / physiology*
  • Evoked Potentials, Visual / physiology*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Multiple Sclerosis / diagnosis*
  • Multiple Sclerosis / physiopathology*
  • Retrospective Studies
  • Severity of Illness Index*